Cargando…

1477. Impact Of Resistance Thresholds On Mortality In Hospital-Acquired And Ventilator-Associated Pneumonia

BACKGROUND: Hospital-acquired (HAP) and ventilator-associated pneumonia (VAP) represent a significant source of morbidity and mortality in hospitalized patients. Numerous studies demonstrate mortality benefit with appropriate empiric therapy. Choosing the right empiric coverage is paramount; however...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazi, Patrick B, Guillamet, M Cristina Vazquez, Micek, Scott, Kollef, Marin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778238/ http://dx.doi.org/10.1093/ofid/ofaa439.1658

Ejemplares similares

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Motowski, Hayley, et al.
Publicado: (2023)

Viruses are prevalent in non-ventilated hospital-acquired pneumonia
por: Shorr, Andrew F., et al.
Publicado: (2017)

2586. Comparison of Antimicrobial Regimens for Critically Ill Patients with Suspected or Confirmed Hospital-Acquired or Ventilator-Associated Pneumonia: A Retrospective, Cohort Study
por: Kosharek, Abigail, et al.
Publicado: (2023)

1008. Cluster Analysis to Define Distinct Clinical Phenotypes Among Septic Patients With Bloodstream Infections
por: Guillamet, M Cristina Vazquez, et al.
Publicado: (2018)

A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?
por: Guillamet, Cristina Vazquez, et al.
Publicado: (2016)

Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia
por: Bittmann, Matthew C., et al.
Publicado: (2022)

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2014)

A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes
por: Micek, Scott T., et al.
Publicado: (2016)

93. Enhanced Oral Care as Prevention for Non-ventilator Hospital Acquired Pneumonia
por: Giuliano, Karen K, et al.
Publicado: (2020)

718 Predictors of Hospital Mortality Among Septic ICU Patients With Acinetobacter spp. Bacteremia: A Cohort Study
por: Shorr, Andrew F., et al.
Publicado: (2014)

Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study
por: Trupka, Tracy, et al.
Publicado: (2017)

Assessment of risk factors for inappropriate empiric antibiotic therapy in patients with Gram-negative sterile site infection complicated by sepsis or septic shock
por: Micek, Scott, et al.
Publicado: (2017)

Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department
por: Micek, Scott T, et al.
Publicado: (2014)

881 New Ventilator Associated Event (VAE) Definition: Persistence of Subjective Variability
por: Mcmullen, Kathleen, et al.
Publicado: (2014)

339 An International, Multicenter, Retrospective Study of Nosocomial Pneumonia due to Pseudomonas aeruginosa
por: Micek, Scott, et al.
Publicado: (2014)

1894. Antimicrobial Stewardship in the Intensive Care Unit: Survey of Critical Care and Infectious Diseases Physicians
por: Guillamet, M Cristina Vazquez, et al.
Publicado: (2018)

Characteristics and outcomes among a hospitalized patient cohort with Streptococcus pneumoniae infection
por: Micek, Scott T., et al.
Publicado: (2020)

382. Incidence of Hospital-Acquired and Ventilator-Associated Pneumonia in Patients with Severe COVID 19 on High Flow Oxygen
por: Papamanoli, Aikaterini, et al.
Publicado: (2020)

Treatment of gram - positive infections in critically ill patients
por: Vazquez-Guillamet, Cristina, et al.
Publicado: (2014)

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
por: Torres, Antoni, et al.
Publicado: (2018)

1477. MUCOVIB Project: Concordance Between Upper and Lower Airway Microbiota in Children with Cystic Fibrosis
por: Asner, Sandra
Publicado: (2018)

P1477: MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL
por: Grace, Rachael F., et al.
Publicado: (2023)

1514. Mortality and Readmission in Adults during the First Year Following Hospitalization for Community-Acquired Pneumonia in the US
por: Sato, Reiko, et al.
Publicado: (2020)

The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic
por: Reynolds, Daniel, et al.
Publicado: (2022)

1476. Objective Surveillance Definitions for Hospital-Acquired Pneumonia in Non-Ventilated Patients
por: Ji, Wenjing, et al.
Publicado: (2018)

Pneumonia Pathogen Characterization Is an Independent Determinant of Hospital Readmission
por: Andruska, Adam, et al.
Publicado: (2015)

Predictors of hospital mortality among septic ICU patients with Acinetobacter spp.bacteremia: a cohort study
por: Shorr, Andrew F, et al.
Publicado: (2014)

1477. Do Federal Risk Assessment Criteria Adequately Classify Patients for Surgical Site Infections Following Colon Surgery?
por: Yusuf, Yasna, et al.
Publicado: (2023)

P1477: CHARACTERIZING SICKLE CELL DISEASE AND BURDEN OF ILLNESS IN THE UNITED STATES OF AMERICA: A RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA
por: Clay, E. L. J., et al.
Publicado: (2022)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

The win ratio method: a novel hierarchical endpoint for pneumonia trials in patients on mechanical ventilation
por: Montgomery, A, et al.
Publicado: (2014)

Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials
por: Burnham, Jason P., et al.
Publicado: (2017)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

A Cool Drink on a Hot Day – Hospital-Acquired Legionella Pneumonia
por: Krystofiak, S.P.
Publicado: (2006)

Implementation of a ventilator care bundle to reduce the incidence of ventilator acquired pneumonia
por: Mandal, AK, et al.
Publicado: (2011)

2599. Impact of Alveolar Neutrophilia on Outcomes in Patients with Suspected Ventilated Hospital-Acquired Bacterial Pneumonia
por: Saravolatz, Louis, et al.
Publicado: (2023)

169. Development of a Real Time Electronic Algorithm to Identify Hospitalized Patients with Community-Acquired Pneumonia
por: Fabre, Valeria, et al.
Publicado: (2020)

1658 C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients
por: Zilberberg, Marya D., et al.
Publicado: (2014)

Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study
por: Shorr, Andrew F, et al.
Publicado: (2013)

Ceftriaxone resistance and adequacy of initial antibiotic therapy in community onset bacterial pneumonia
por: Van Besien, Richard F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u6jg0vr7701rv3556tjh1j8hid